Cavanaugh Sarah 4
4 · Celldex Therapeutics, Inc. · Filed Jun 17, 2024
Insider Transaction Report
Form 4
Cavanaugh Sarah
SVP OF CORP AFFAIRS & ADMIN.
Transactions
- Award
Incentive Stock Option (right to buy)
2024-06-13+78,000→ 78,000 totalExercise: $36.43From: 2025-06-13Exp: 2034-06-13→ Common Stock (78,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- [F2]25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.